Development of an Inhibition ELISA test for the detection on non-capsid polyprotein 3 ABC in viral suspensions destines to anactivated foot-and-mouth diseases vaccines.

BERGMANN IE; MALIRAT V; NEITZERT E; DE MENDONÇA CAMPOS R,; PULGA M; MURATOVIK R; QUINTINO D; MORGADO JC; OLIVEIRA M; LUCCA NETTO D.

Developments in Biologicals

S. Karger AG

Año: 2006 vol. 126 p. 241 - 250

1424-6074

The use during the last decade of immuno-enzymatic tests based on the detection of antibodies to the non-capsid proteins (NCPs) of foot-and-mouth disease virus (FMDV) to assess viral circulation, irrespective of vaccination, supported the incorporation into the OIE code of the ´free from FMDV with vaccination´ category and opened the way to a ´vaccination to live´ policy. Eradication programmes in South America include systematic vaccination accompanied by large serosurveys through NCP antibody testing to ensure the absence of residual viral activity. For correct interpretation of serosurveys, a major prerequisite is that vaccines made of semi-purified preparations of inactivated virions do not contain levels of NCPs, which upon proper presentation conditions, could induce an antibody response under the conditions for field immunization. This work describes the development of an inhibition ELISA to detect NCP polyprotein 3ABC in viral suspensions destined for vaccine production as an in-process control during vaccine manufacture. Antibody responses against NCP 3ABC in vaccinated and revaccinated cattle, induced by vaccines with different purification processes and formulations, are discussed.